Study offers new way to discover HIV vaccine targets
Ragon Institute researchers develop a method to identify weak points in viral proteins that could be exploited for vaccine development.
Ragon Institute researchers develop a method to identify weak points in viral proteins that could be exploited for vaccine development.
Enlisted in the fight against HIV, MIT engineers and scientists contribute new technology, materials and computational studies.
New technology could help AIDS researchers develop new vaccines.
Vaccines that target newly identified viral protein sequences could be more effective than previous efforts.
A new finding from the Ragon Institute of MGH, MIT and Harvard may have implications for designing an effective AIDS vaccine.
Partial success of a new AIDS vaccine offers clues to help develop a stronger vaccine, say MIT’s Arup Chakraborty and MGH’s Bruce Walker.